Some of the upregulated inflammatory pathways potentially implicated in T1D pathogenesis were also reported to adopt, in some cases, an immunomodulatory effect, reducing the overstimulation of the immune system and sparing tissue damage (22), like HER2/HER3, HGF, CATG and LTF pathways. This evidence concerns the gene ERBB2 and type 1 diabetes mellitus.